Cumulative Exposure to Ideal Cardiovascular Health and Incident Diabetes in a Chinese Population: The Kailuan Study by Liu, X. et al.
Cumulative Exposure to Ideal Cardiovascular Health and Incident
Diabetes in a Chinese Population: The Kailuan Study
Xiaoxue Liu,MD;* LiufuCui,MD;*AnxinWang, PhD; XizhuWang,MD, PhD;QiaofengSong,MD, PhD; ShanshanLi,MD, PhD; JihongShi,MD, PhD;
Xiaohong Zhao, MD; Shuohua Chen, MD; Xin Du, MD; Chunpeng Ji, MD; Rachel Huxley, PhD; Yuming Guo, MD, PhD; Shouling Wu, MD, PhD
Background-—It is unclear whether ideal cardiovascular health (CVH), and particularly cumulative exposure to ideal CVH (cumCVH),
is associated with incident diabetes. We aimed to fill this research gap.
Methods and Results-—The Kailuan Study is a prospective cohort of 101 510 adults aged 18 to 98 years recruited in 2006–2007
and who were subsequently followed up at 2- (Exam 2), 4- (Exam 3), and 6 (Exam 4)-year intervals after baseline. The main analysis
is restricted to those individuals with complete follow-up at all 4 examinations and who had no history of diabetes until Exam 3.
Cumulative exposure to ideal CVH (cumCVH) was calculated as the summed CVH score for each examination multiplied by the time
between the 2 examinations (score9year). Logistic regression models were used to assess the association between cumCVH and
incident diabetes. In fully adjusted models, compared with the lowest quintile of cumCVH, individuals in the highest quintile had
~68% (95% confidence interval [CI] 60-75) lower risk for incident diabetes (compared with 61% [95% CI 52-69] lower risk when
using baseline CVH). Every additional year lived with a 1-unit increase in ideal CVH was associated with a 24% (95% CI 21-28)
reduction in incident diabetes.
Conclusions-—Ideal CVH is associated with a reduced incidence of diabetes, but the association is likely to be underestimated if
baseline measures of CVH exposure are used. Measures of cumulative exposure to ideal CVH are more likely to reflect lifetime risk
of diabetes and possibly other health outcomes.
Clinical Trial Registration-—URL: https://www.chictr.org. Unique identifier: ChiCTRTNC-11001489. ( J Am Heart Assoc. 2016;5:
e004132 doi: 10.1161/JAHA.116.004132)
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I n January 2010 the American Heart Association (AHA)defined the concept of ideal cardiovascular health (CVH)
as the simultaneous presence of 4 ideal health behaviors
(nonsmoking, normal body mass index [BMI], being physically
active, and having a healthy diet) combined with 3 ideal health
factors (normal levels of total cholesterol, blood pressure, and
fasting blood glucose).1 Evidence from prospective studies
have suggested that having ideal CVH is associated with a
protective effect against the development of subclinical
atherosclerosis,2,3 metabolic syndrome,4 stroke,5 cardiovas-
cular disease,6,7 cancer,8 and all-cause mortality.9-11
An inherent limitation of previous studies, however, has
been the reliance on a single time point by which to assess
CVH, which may have occurred several decades prior to the
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event and is therefore likely to yield biased estimates of the
association. Moreover, there has been no consideration of
how these health metrics vary within individuals over time and
the subsequent impact that this would have on the cumulative
exposure to CVH and future risk of disease. To the best of our
knowledge, there have been no data published on the
association between ideal CVH—in particular, cumulative
exposure to ideal CVH (cumCVH)—and new-onset diabetes,
which is an independent predictor of cardiovascular events
and all-cause mortality.12 Hence, the objective of the current
study was to explore and quantify the prospective association
between cumCVH and incident diabetes in the Chinese
population using the Kailuan Study.
Methods
Study Population
The Kailuan Study7 is a prospective cohort study conducted in
the Kailuan community in Tangshan city, China. From June
2006 to October 2007, a total of 101 510 participants
(81 110 men and 20 400 women, aged 18–98 years) were
recruited (Exam 1) and were followed-up in 3 visits in 2008–
2009 (Exam 2), 2010–2011 (Exam 3), and 2012–2013 (Exam
4). The primary analysis is based on a subgroup of 34 323
individuals (25 961 men and 8362 women) for whom
complete follow-up data were available and who did not have
a diagnosis of diabetes prior to Exam 4 (Figure 1). The study
was approved by the Ethics Committees of Kailuan General
Hospital following the guidelines outlined by the Helsinki
Declaration. All participants agreed to participate in this study
and provided written informed consent.
Assessment of Cardiovascular Health Metrics
Information on smoking, physical activity, and salt intake (as a
proxy for diet) was collected via questionnaires at baseline
and during each of the 3 follow-up visits. Smoking status was
based on self-report and classified as “never” (ideal health
behavior), “former” (intermediate health behavior), or “cur-
rent” (poor health behavior). Information on physical activity
level (minutes of moderate or vigorous activity per week) was
obtained from questionnaires and categorized as follows: ≥80
(ideal); 1 to 79 (intermediate) and; 0 (poor) minutes of
moderate or vigorous activity per week.5 Because information
on dietary pattern was not available, the amount of salt used
during cooking was used as a surrogate marker, as studies
have shown that high intakes of salt are correlated with poor
dietary patterns.13 We collected 24-hour dietary salt intake for
this study. A standard spoon was used for participants to
recall how much salt they ate in the last 24 hours. Self-
reported use of salt was classified as “low” (<6 g/day,
representing “ideal”), “medium” (6–10 g/day; “intermedi-
ate”), or “high” (>10 g/day; “poor”). In a random sample of
1000 participants, 24-hour natriuresis was measured to
determine the correlation with self-reported use of salt. The
correlation was high (r=0.78), indicating that self-reported use
of salt was associated with actual salt intake in this study.
Height was measured to an accuracy of 0.1 cm using a
tape measure, and weight was measured to the nearest
0.1 kg with calibrated platform scales. Body mass index (BMI)
was calculated as body weight (kg) divided by the square of
height (m2). Using the AHA definitions,1 BMI was classified as
ideal (<25 kg/m2), intermediate (25–29.9 kg/m2), or poor
(≥30 kg/m2).5,7,11,14 Blood pressure (BP) was measured by a
mercury sphygmomanometer. Three readings of systolic and
diastolic blood pressure (SBP and DBP) were taken at 5-
minute intervals after participants had rested in a chair for at
least 5 minutes. Blood pressure was classified as ideal (SBP
<120 mm Hg and DBP <80 mm Hg and untreated with BP-
lowering medications), intermediate (120 mm Hg ≤ SBP
≤139 mm Hg, 80 mm Hg ≤ DBP ≤89 mm Hg, or treated to
SBP/DBP <120/80 mm Hg), or poor (SBP ≥140 mm Hg,
DBP ≥90 mm Hg, or treated to SBP/DBP >120/80 mm Hg).
Blood samples were collected from the antecubital vein after
overnight fasting. Fasting blood glucose (FBG) was measured
using the hexokinase/glucose-6-phosphate-dehydrogenase
method.15 FBG was classified as ideal (<5.6 mmol/L
and untreated), intermediate (5.6–6.9 mmol/L or treated to
<5.6 mmol/L), or poor (≥7.0 mmol/L or treated to
≥5.6 mmol/L). Total cholesterol (TC) and triglycerides were
measured enzymatically. Total cholesterol status was classified
as ideal (<200 mg/dL and untreated), intermediate (200–
239 mg/dL or treated to <200 mg/dL), or poor (≥240 mg/dL
or treated to ≥200 mg/dL), respectively.
Assessment of Potential Covariates
A 10-second 12-lead electrocardiogram was used to measure
the resting heart rate (RHR) after the individual had rested in
the supine position for 5 minutes. The number of R-R intervals
(number of QRS complexes–1) was divided by the time
difference between the first and last beat, and the results
were converted to beats per minute (bpm).16 High-density
lipoprotein cholesterol (HDL-C) and LDL-C levels were mea-
sured using a direct test method17 (interassay coefficient of
variation <10%; Mind Bioengineering Co, Ltd, Shanghai,
China). “High-sensitivity” C-reactive protein (hs-CRP) was
measured by a high-sensitivity nephelometry assay (Cias
Latex CRP-H, Kanto Chemical, Tokyo, Japan). Serum uric acid
(UA) concentrations were measured using an oxidase method.
All biochemical variables were measured at the central
laboratory of Kailuan General Hospital with use of a Hitachi
autoanalyzer (Hitachi 747; Hitachi, Tokyo, Japan).
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Information on demographic and clinical characteristics
(age, sex, alcohol use, personal monthly income, education,
and history of diseases) was collected via questionnaire at
study baseline. Participants were classified into 3 categories:
<40, 40 to 59, and ≥60 years according to baseline age.
Previous history of disease, including myocardial infarction,
stroke, and cancer, was collected by self-report. The use of
antihypertensive, cholesterol-lowering, and glucose-lowering
medications within the past 2 weeks before the baseline
interview was also self-reported. The average monthly income
was categorized as “<¥600,” “¥600 to ¥800,” or “≥¥800.” The
educational attainment was categorized as “illiteracy or
primary,” “middle school,” and “high school or above.”
Cumulative Exposure to Ideal Cardiovascular
Health
To examine the association between cumulative exposure to
CVH metrics (except the FBG metric), a dichotomized variable
for each component of the health metrics was created:
“ideal”=2; “intermediate”=1; and “poor”=0. The total ideal
CVH score of each individual was the sum score of the 6 ideal
CVH metrics and ranged from 0 to 12. CumCVH was defined
as the summed CVH score for each examination multiplied by
the time between the two consecutive visits in years:
CVH19time1–2+CVH29time2–3+CVH39time3–4, where CVH1,
CVH2, and CVH3 indicate CVH at examinations 1 (baseline), 2,
and 3, and time1–2, time2–3, time3–4, indicate the participant-
specific time intervals between consecutive Exams 1 to 3, in
years. Participants were categorized into quintiles of cumCVH
point score: Quintile 1 <39 points; Quintile 2 39 to 43 points;
Quintile 3 44 to 48 points; Quintile 4 49 to 54 points; and
Quintile 5 ≥55 points.
Assessment of New-Onset Diabetes
In line with the ADA guidelines, participants were diagnosed
with diabetes mellitus at Exam 4 (2012–2013) if they were
currently treated with insulin or oral hypoglycaemic agents or
had a FBG concentration ≥7.0 mmol/L.18
49713 participants Eaxms 1, 2 and 3
40115 participants Eaxms 1, 2, 3 and 4
8025 participants who did not participate in the 
2012 survey were excluded
34323 participants were included in the 
analysis
5792 participants who missed data on 
cardiovascular health indicator were excluded
68705 participants Eaxms 1 and 2
101510 participants who participated in the 
2006 survey Eaxm 1
23316 participants who did not participate in the 
2008 survey were excluded
15631 participants who did not participate in the 
2010 survey were excluded
9489 participants who were diagnosed 
diabetes before 2006 were excluded
3361 participants were diagnosed with 
diabetes before 2008 were excluded
1573 participants who were diagnosed 
diabetes before 2010 were excluded
Figure 1. Selection of Kailuan study participants for analysis.
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Table 1. Characteristics of Studied Participants in 2006 According to Cumulative Exposure of CVH
Group of Cumulative Exposure of CVH
P ValueQ1 Q2 Q3 Q4 Q5
Cardiovascular Health scores 5 (5–6) 7 (6–8) 7 (7–8) 8 (8–9) 9 (9–10) <0.001
No. of participants, n 6864 6865 6864 6866 6864
Age, y 46.009.91 47.3411.10 47.5011.46 47.9312.28 48.3512.98 <0.001
Men, n (%) 6439 (93.81) 5944 (86.58) 5491 (80.00) 4663 (67.91) 3424 (49.88) <0.001
Education, n (%) <0.001
Illiteracy/primary school 468 (6.82) 473 (6.89) 428 (6.24) 422 (6.15) 405 (5.90)
Middle school 4822 (70.31) 4935 (71.90) 4959 (72.30) 4791 (69.80) 4456 (64.95)
High school or above 1568 (22.86) 1456 (21.21) 1472 (21.46) 1651 (24.05) 2000 (29.15)
Income, ¥/month, n (%) <0.001
<¥600 2582 (37.64) 2036 (29.67) 1896 (27.63) 1805 (26.30) 1540 (22.46)
¥600 to ¥800 3176 (46.30) 3811 (55.55) 4024 (58.65) 4086 (59.54) 4207 (61.34)
≥¥800 1102 (16.06) 1014 (14.78) 941 (13.72) 972 (14.16) 1111 (16.20)
Alcohol drinking, n (%) <0.001
Never 2305 (33.61) 3486 (50.82) 4149 (60.50) 4725 (68.84) 5248 (76.50)
Past 250 (3.64) 230 (3.35) 181 (2.64) 150 (2.19) 127 (1.85)
Current, <1 times/day 2045 (29.81) 1670 (24.34) 1501 (21.89) 1278 (18.62) 1024 (14.93)
Current, 1+times/day 2259 (32.93) 1474 (21.49) 1027 (14.98) 711 (10.36) 461 (6.72)
Smoking, n (%) <0.001
Poor 4293 (62.54) 2763 (40.25) 1884 (27.45) 1076 (15.67) 422 (6.15)
Intermediate 652 (9.50) 725 (10.56) 690 (10.05) 556 (8.10) 370 (5.39)
Ideal 1919 (27.96) 3377 (49.19) 4290 (62.50) 5234 (76.23) 6072 (88.46)
Physical activity, n (%) <0.001
Poor 1126 (16.40) 752 (10.95) 581 (8.46) 417 (6.07 243 (3.54)
Intermediate 5140 (74.88) 5394 (78.59) 5471 (79.71) 5431 (79.10) 5158 (75.15)
Ideal 598 (8.71) 718 (10.46) 812 (11.83) 1018 (14.83) 1463 (21.31)
Salt intake, n (%) <0.001
Poor 1485 (21.63) 812 (11.83) 568 (8.28) 416 (6.06) 285 (4.15)
Intermediate 4970 (72.41) 5551 (80.86) 5704 (83.10) 5801 (84.49) 5603 (81.63)
Ideal 409 (5.96) 502 (7.31) 592 (8.62) 649 (9.45) 976 (14.22)
BMI, kg/m2 27.123.41 25.743.30 24.843.12 24.032.87 22.722.60 <0.001
Systolic blood pressure,
mm Hg
135.3819.61 130.6718.99 127.4418.43 124.0418.02 117.5316.47 <0.001
Diastolic blood pressure,
mm Hg
87.9311.67 84.4310.84 82.4410.54 80.0910.05 76.079.36 <0.001
Fasting blood glucose
concentration, mmol/L
5.130.67 5.060.66 5.020.64 4.980.64 4.910.60 <0.001
Total cholesterol concentration,
mmol/L
5.411.22 4.971.17 4.771.09 4.681.04 4.530.88 <0.001
Resting heart rate, bpm 74.549.86 73.459.44 73.019.63 72.729.63 72.009.45 <0.001
Uric acid, lmol/L 314.8285.49 292.2780.27 280.1678.18 270.9277.70 260.9974.80 <0.001
High-sensitivity C-reactive protein, mg/L 0.90 (0.40–2.29) 0.75 (0.30–2.08) 0.68 (0.24–1.77) 0.60 (0.22–1.66) 0.45 (0.19–1.30) <0.001
Education level (elementary school, high school, or college or above), income level (income ≥ ¥800/month, ¥600 to ¥800/month, and <¥600/month), drinking (never, past, current
<1 time/day, or current, 1+times/day). BMI indicates body mass index; CVH, ideal cardiovascular health; Q1, quintile 1; Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5.
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Continuous variables were described as meanstandard
deviation (SD) and were compared by ANOVA or the
Kruskal-Wallis test. Categorical variables were described as
percentages and were compared using v2 tests. A logistic
regression model was used to estimate the risk of diabetes
associated with cumCVH metrics (primary analysis) and with
CVH at study baseline (secondary analysis). Odds ratios (ORs)
and 95% CIs were calculated. We fitted 3 multivariate models.
Model 1 adjusted for age and sex. Model 2 additionally
adjusted for education level, income level, and alcohol
consumption. Model 3 further adjusted for hs-CRP, UA, RHR
in 2006, and medication usage before 2012. The interactions
of cumCVH with sex and age on risk of diabetes were
assessed. Because there were 11 hospitals that conducted
the laboratory test assays, we used a random effect for each
hospital to account for the potential measurement bias.
We conducted several sensitivity analyses to test the
robustness of our findings: first, individuals with a prior history
of cardiovascular diseases (CVD) at Exam 4 were excluded;
second, because duration of follow-up is likely to have
influenced an individual’s exposure to cumCVH, a time-
weighted cumCVH model was used to assess the association
between CVH and incident diabetes. The time-weighted
cumCVH was calculated by (CVH19time1–2+CVH29time2–
3+CVH39time3–4)/(time1–2+time2–3+time3–4). Third, to check
whether exclusion of missing data (~60%) influenced the main
Table 2. Odds Ratios and 95% Confidence Intervals of Diabetes in Relation to Quintile and Unit Increase in Cumulative Exposure of
CVH
Group of Cumulative Exposure of CVH
1 Unit Increase P for TrendQ1 Q2 Q3 Q4 Q5
Total, n 6864 6865 6864 6866 6864
Case number, n (%) 423 (6.16) 295 (4.30) 266 (3.88) 167 (2.43) 150 (2.19)
Model 1* 1.00 0.64 (0.55–0.74) 0.56 (0.48–0.66) 0.33 (0.28–0.40) 0.28 (0.23–0.35) 0.95 (0.95–0.96) <0.001
Model 2† 1.00 0.63 (0.54–0.74) 0.55 (0.47–0.65) 0.32 (0.27–0.39) 0.28 (0.23–0.34) 0.95 (0.95–0.96) <0.001
Model 3‡ 1.00 0.69 (0.59–0.81) 0.62 (0.52–0.73) 0.35 (0.28–0.43) 0.32 (0.25–0.40) 0.96 (0.95–0.96) <0.001
Sex
Women 42 (9.88) 47 (5.10) 63 (4.59) 56 (2.54) 67 (1.95)
Model 3‡ 1.00 0.57 (0.36–0.92) 0.65 (0.41–1.01) 0.39 (0.24–0.62) 0.30 (0.18–0.47) 0.95 (0.94–0.97) <0.001
Men 381 (5.92) 248 (4.17) 203 (3.70) 111 (2.38) 83 (2.42)
Model 3‡ 1.00 0.71 (0.60–0.84) 0.61 (0.50–0.73) 0.33 (0.26–0.42) 0.35 (0.27–0.46) 0.96 (0.95–0.97) <0.001
P-interaction 0.311 0.885 0.958 0.218
Age, y
<40 65 (3.86) 39 (2.42) 24 (1.44) 13 (0.73) 12 (0.64)
Model 3‡ 1.00 0.75 (0.49–1.14) 0.46 (0.28–0.76) 0.22 (0.12–0.43) 0.23 (0.11–0.47) 0.95 (0.93–0.96) <0.001
40 to 59 304 (6.51) 210 (4.75) 187 (4.37) 109 (2.72) 97 (2.58)
Model 3‡ 1.00 0.75 (0.62–0.91) 0.69 (0.56–0.84) 0.40 (0.31–0.51) 0.37 (0.28–0.49) 0.96 (0.95–0.97) <0.001
P-interaction 0.572 0.027 0.017 0.021
≥60 54 (10.59) 46 (5.51) 55 (6.00) 45 (4.16) 41 (3.33)
Model 3‡ 1.00 0.49 (0.32–0.75) 0.57 (0.37–0.86) 0.33 (0.21–0.53) 0.30 (0.18–0.47) 0.96 (0.94–0.98) <0.001
P-interaction 0.345 0.209 0.101 0.143
Sensitivity analysis
Model 4§ 1.00 0.69 (0.59–0.82) 0.63 (0.53–0.74) 0.35 (0.28–0.43) 0.32 (0.26–0.40) 0.96 (0.95–0.97) <0.001
CVH indicates ideal cardiovascular health; Q1, quintile 1; Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5.
*Adjusted for age (years), sex.
†Adjusted for as Model 1 plus education level (elementary school, high school, or college or above), income level (income ≥ ¥800/month, ¥600 to ¥800/month, and < ¥600/month), and
drinking (never, past, current <1 times/day or current 1+times/day).
‡Adjusted for as model 2 plus high-sensitivity C-reactive protein, uric acid, resting heart rate at Exam 1 and medication usage before Exam 4.
§Adjusted for Model 3 and further excluded individuals with cardiovascular disease (myocardial infarction) before Exam 4.
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findings, we examined the relationship between CVH at
baseline (Exam 1) and incident diabetes (at Exam 2). Finally,
the individual influence that each of the 6 CVH metrics had on
risk of incident diabetes was examined after excluding each of
the 7 metrics from the cumCVH score in turn. All statistical
analyses were performed using SAS 9.3 (SAS Institute, Cary,
NC). All statistical tests were 2-sided, and the significance
level was set at P<0.05.
Results
Baseline participant characteristics stratified by quintile of
cumCVH exposure are shown in Table 1. In general,
participants in the lowest quintile for cumCVH were younger.
In addition, participants in the lowest quintile for cumCVH
were predominantly male, were less educated, and had lower
monthly incomes than those in higher quintiles. The distribu-
tion of CVH indices across quintiles of cumCVH differed by
sex most notably for smoking (very few women were current
or former smokers) and BMI (more overweight and obese
women than men irrespective of quintile) (Table S1).
During a meanSD follow-up of 6.30.50 years there
were 1301 (21% women) cases of incident diabetes (Exam 4).
Table 2 shows the adjusted odds ratios (ORs) of incident
diabetes associated with quintiles of cumCVH exposure. The

















































Figure 2. Odds ratios (and 95% confidence intervals) of diabetes in relation to quintile increase in
cumulative exposure of ideal cardiovascular health behaviors (smoking, diet, exercise, and BMI).
Q1=quintile 1, Q2=quintile 2, Q3=quintile 3, Q4=quintile 4, Q5=quintile 5. Model 1: adjusted for age
(years), sex. Model 2: adjusted as for Model 1 plus education level (elementary school, high school, or
college or above), income level (income ≥ ¥800/month, ¥600 to ¥800, and income < ¥600/month), and
drinking (never, past, current, <1 times/day or current, 1+times/day). Model 3: adjusted as for Model 2
plus high-sensitivity C-reactive protein, uric acid, resting heart rate at Exam 1, and medication usage
before Exam 4. Model 4: adjusted as for Model 3 and further excluded individuals with cardiovascular
disease (myocardial infarction) before Exam 4. BMI indicates body mass index.
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lowest quintile of cumCVH to 2.19% in the highest. In the fully
adjusted model, compared with participants in the lowest
quintile, those in the highest quintile for cumCVH exposure
had ~68% lower risk of developing diabetes (OR 0.32; 95%, CI
0.25–0.40). For every unit increase in cumCVH, the risk of
diabetes decreased by ~4% (OR 0.96, 95% CI 0.95–0.96). The
effect was consistent across sex and age groups (Table 2) and
did not materially differ following exclusion of the individual
risk factors. Exclusion of individuals with a prior history of
CVD did not materially affect the results (Table 2). The ideal
health behaviors (smoking, diet, exercise, and BMI) also
reduced the odds of diabetes (Figure 2).
The results using the time-weighted cumulative exposure
to CVH were highly comparable to the unweighted model
(Table S2). In the fully adjusted model every additional year
lived with a 1-unit increase in ideal CVH was associated with a
24% (95% CI 21–28) reduction in incident diabetes. Further-
more, when we excluded each of the 6 metrics from the
cumCVH score in turn, the association was unaffected
following exclusion of individual risk factors (Figure 3).
Table 3 shows the adjusted ORs of incident diabetes
associated with quintiles of baseline CVH exposure. In the
fully adjusted model, compared with participants in the lowest
quintile, those in the highest quintile for CVH exposure were
at 61% lower risk of developing diabetes (OR 0.39, 95% CI
0.31–0.48). For every unit increase in CVH, the risk of
diabetes decreased by 17% (OR 0.83, 95% CI 0.80–0.86).
The effect was consistent across sex and age groups
(Table 3). Similar results were observed when the analysis
was conducted in participants (n=65 185) who attended only
the first follow-up examination (Exam 2) (Table S3).
Table S4 shows comparison of demographic and other
characteristics of participants and nonparticipants. The
individuals included in the present study were significantly
younger (47.4311.62 years) than excluded participants
(53.8512.97 years); had a higher level of education
(23.75% vs 18.80%; P<0.001); and had lower levels of systolic
blood pressure, diastolic blood pressure, fasting blood
glucose, total cholesterol, high-sensitivity C-reactive protein
concentration, uric acid concentration, and resting heart rate
(Table S4).
Discussion
The concept of “ideal cardiovascular health” recognizes that
vascular risk factors—such as high blood pressure, diabetes,
cigarette smoking, and poor diet—frequently cluster and that
an aggregate measure of these risk factors is likely to be a
truer reflection of an individual’s level of vascular risk than any
single risk factor in isolation. Findings from the current study
extend previous work2-4,6,8,9,19 (Table S5) by demonstrating
for the first time that ideal CVH is associated with a
substantially lower risk of incident diabetes compared with
those with poor CVH when measured either at baseline or
cumulatively: specifically, every additional year lived with a
1-unit increase in ideal CVH was associated with a 24%
reduction in incident diabetes.
The associations were broadly similar in subgroups strat-
ified by sex and age and after adjusting for potential
confounders. In addition, participants in the lowest quintile
for cumCVH were younger. This might be caused by the fact
that younger people have to spend more time working and do
not pay attention to their health care. The young have more
living pressure because of their low income. Moreover, our
results show that the relationship between CVH and incident
diabetes (and possibly other vascular outcomes) is likely to be
CVH without total cholesterol
CVH without smoke
CVH without physical exercise
CVH without salt
CVH without body mass index










0.90 0.92 0.94 0.96 0.98 1.00
Figure 3. Odds ratios and 95% confidence intervals of diabetes in relation to a 1-unit increase in
cumulative exposure of ideal cardiovascular health, following individual exclusion of cardiovascular health
metrics. The models adjusted for age, sex, education level, income level, drinking, high-sensitivity C-reactive
protein, uric acid, resting heart rate at Exam 1, and medication usage before Exam 4.
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underestimated when a single measure of exposure at study
baseline is used as opposed to a cumulative measure. These
findings thus provide the first evidence that mid- to long-term
exposure to CVH is not only strongly associated with future
risk of diabetes but that it is likely to be a more accurate
indicator of the true magnitude of risk as compared with a
single measure of CVH done several years before the onset of
diabetes.
Over the last 2 decades the prevalence of diabetes in
China has more than quadrupled from 2.5% in 1994 to an
estimated 11.6% in 2010, paralleling the rapid increase in the
prevalence of overweight and obesity in the population that
has occurred.20 By 2030 it is estimated that the prevalence of
diabetes in China will increase further to 42.3 million people
living with diabetes.21 Although much of the estimated
increase in diabetes prevalence is due to China’s aging
population,22,23 our findings suggest that widespread adop-
tion of public health interventions that target the prevention
or prompt reversal of adverse health behaviors such as
smoking, high salt intake, and physical inactivity may have a
beneficial impact on reducing the incidence of diabetes
across the life course. This proposition is supported by
intervention and observational studies that have shown that
diabetes is amenable to lifestyle interventions.24-29 For
example, in the Finnish Diabetes Prevention Study, Tuomile-
hto et al reported a lower incidence of diabetes among
middle-aged men who adopted a healthier lifestyle that
included weight loss, improved dietary habits, and increased
physical activity relative to men who did not alter their
behavior.25 Smoking cessation has also been associated with
a reduced risk of incident diabetes,27 whereas cumulative
exposure to obesity (ie, duration and degree of overweight) is
positively associated with diabetes risk.30-32 In our study
cumulative exposure to healthy behaviors (not smoking, diet,
exercise, and weight loss) is also associated with a reduced
diabetes incidence.
The current study is unique in that the measure of
cumulative CVH exposure included 5 (smoking, BMI, physical
Table 3. Odds Ratios and 95% Confidence Intervals of Diabetes (Exam 4) in Relation to Quintile Increase of Baseline CVH
Group of Baseline CVH
1 Unit Increase P for TrendQ1 Q2 Q3 Q4 Q5
Total, n 4877 5078 7177 7634 9557
Case number, n (%) 298 (6.11) 244 (4.81) 321 (4.47) 226 (2.96) 212 (2.22)
Model 1* 1.00 0.75 (0.63–0.90) 0.68 (0.58–0.81) 0.45 (0.37–0.54) 0.35 (0.29–0.42) 0.81 (0.78–0.83) <0.001
Model 2† 1.00 0.74 (0.62–0.88) 0.66 (0.56–0.78) 0.42 (0.35–0.51) 0.33 (0.27–0.40) 0.80 (0.77–0.83) <0.001
Model 3‡ 1.00 0.78 (0.65–0.94) 0.73 (0.61–0.87) 0.50 (0.41–0.60) 0.39 (0.31–0.48) 0.83 (0.80–0.86) <0.001
Sex
Women 18 (7.29) 42 (7.07) 70 (5.43) 63 (3.28) 82 (1.90)
Model 3‡ 1.00 1.00 (0.54–1.86) 0.91 (0.51–1.64) 0.63 (0.35–1.15) 0.44 (0.24–0.81) 0.81 (0.73–0.89) <0.001
Men 280 (6.05) 202 (4.50) 251 (4.26) 163 (2.85) 130 (2.48)
Model 3‡ 1.00 0.75 (0.62–0.91) 0.71 (0.59–0.85) 0.48 (0.39–0.60) 0.41 (0.32–0.52) 0.84 (0.80–0.87) <0.001
P-interaction 0.376 0.547 0.614 0.757
Age, y
<40 42 (4.13) 33 (3.04) 29 (1.87) 21 (1.13) 28 (0.90)
Model 3‡ 1.00 0.82 (0.51–1.33) 0.54 (0.33–0.90) 0.35 (0.20–0.61) 0.32 (0.18–0.56) 0.82 (0.74–0.91) <0.001
40 to 59 215 (6.43) 173 (5.23) 222 (4.91) 161 (3.48) 136 (2.55)
Model 3‡ 1.00 0.79 (0.64–0.98) 0.78 (0.63–0.96) 0.55 (0.44–0.70) 0.40 (0.31–0.52) 0.84 (0.80–0.88) <0.001
P-interaction 0.875 0.053 0.021 0.035
≥60 41 (7.95) 38 (5.53) 70 (6.35) 44 (3.85) 48 (4.26)
Model 3‡ 1.00 0.74 (0.46–1.20) 0.80 (0.51–1.23) 0.50 (0.31–0.82) 0.56 (0.34–0.92) 0.87 (0.79–0.95) <0.001
P-interaction 0.976 0.110 0.112 0.008
CVH indicates ideal cardiovascular health; Q1, quintile 1; Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5.
*Adjusted for age (years), sex.
†Adjusted for as Model 1 plus education level (elementary school, high school, or college or above), income level (income ≥ ¥800/month, ¥600 to ¥800/month, and income < ¥600/
month), and drinking (never, past, current <1 time/day, or current 1+times/day).
‡Adjusted for as Model 2 plus high-sensitivity C-reactive protein, uric acid, resting heart rate at Exam 1, and medication usage before Exam 4.
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activity, blood pressure, and total cholesterol) out of the 7
indices that define the AHA’s ideal CVH index (with salt use as
a proxy of diet). Furthermore, each of these individual risk
factors appeared to confer similar risks of diabetes, as the
association between cumCVH exposure and incident diabetes
was attenuated to a comparable extent following their
individual removal from the model (Figure 3). These findings
imply that preventative efforts to reduce diabetes incidence
that encompass strategies that promote a more holistic
approach to optimal vascular health (eg, smoking cessation,
weight loss, increased physical activity, low-fat diets) may
yield greater benefits than would be expected by targeting
individual health behaviors alone.
The biological mechanisms underpinning the association
between low ideal CVH and incident diabetes remain spec-
ulative but are likely to be driven by increased insulin
resistance and inflammation. Obesity, cigarette smoking,
physical inactivity, and poor diet have each been reported to
increase insulin resistance,33-36 which in turn is associated
with increased plasma concentrations of free fatty acids,37
elevated plasma concentrations of proinflammatory cytoki-
nes,38,39 and increased oxidative stress.40,41
Strengths and Limitations
Our study has several strengths: it is the first prospective
study to address the association between cumulative expo-
sure to CVH and incident diabetes in a well-characterized
population. Other strengths of our study include its large
sample size and information on a broad spectrum of biological
and behavioral covariates. However, as with all observational
studies, there are some inherent limitations. First, we had no
information on dietary habits and therefore used self-reported
salt intake as a surrogate indicator of dietary behavior.
Previous studies have documented the correlation between
the “healthfulness” of different dietary patterns with salt
intake and showed that the least optimal diets were those
containing the most salt. In the current study the correlation
between self-reported salt intake and 24-hour natriuresis
among 1000 randomly selected participants was high
(r=0.78), indicating good agreement between self-reported
salt intake and salt excretion. Second, as all participants were
recruited from Tangshan city (an industrial city located in
northern China), the cohort is not nationally representative,
and thus the findings pertaining to the prevalence of CVH are
not generalizable to other parts of China. In contrast, the
primary outcome was the estimate of the relative risk of
diabetes associated with cumCVH exposure that should be
generalizable to the Chinese population (which is supported
by the robustness of the findings across age and sex
groups).Third, the diagnosis of diabetes was based on a
single measure of FBG at Exam 4 without using the oral
glucose tolerance test (OGTT), which is due to lack of
availability of oral glucose tolerance test data for such a large
cohort. Finally, a substantial portion of the participants were
dropped from subsequent exams, which might underestimate
the benefits of CVH on diabetes. When we compared the
characteristics of the final participants and the excluded
participants, the results showed that the excluded partici-
pants potentially have a higher risk of diabetes compared with
the included participants.
In summary, the current findings demonstrate the impor-
tance of reducing chronic exposure to adverse health
behaviors and risk factors in order to minimize the future
risk of diabetes. The study also highlights the need to take
into consideration cumulative exposure when estimating risk
rather than relying on a single measure of exposure that can
often precede the outcome by several decades. In China,
public health campaigns that promote, encourage, and
support individuals to maintain or adopt a healthier lifestyle
early in life or during midlife could have significant beneficial
effects in stemming the growing prevalence of diabetes.
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Table S1.The percentages of each of the seven cardiovascular health indices according to cumulative exposure of CVH. 
 Group of cumulative exposure of CVH 
 Women  Men 
CVH metrics Q1 Q2 Q3 Q4 Q5 P value  Q1 Q2 Q3 Q4 Q5 P value 
Smoking, %      <0.001       <0.001 
Ideal   92.24 97.39 97.31 98.73 99.65   23.71 41.72 53.80 65.60 77.22  
Intermediate   2.59 0.87 1.31 0.68 0.23   9.95 12.06 12.24 11.60 10.57  
 Poor  5.18 1.74 1.38 0.59 0.12   66.33 46.21 33.96 22.80 12.21  
Body mass index, %      <0.001       <0.001 
Ideal  8.00 21.61 41.95 63.23 85.90   26.00 43.19 55.22 66.55 82.80  
Intermediate  52.00 56.35 49.09 33.86 13.14   56.00 50.02 41.27 31.83 16.68  
Poor   40.00 22.04 8.96 2.91 0.96   18.00 6.80 3.51 1.63 0.53  
Physical activity, %      <0.001       <0.001 
Ideal   10.12 9.88 9.18 10.26 15.84   8.62 10.55 12.49 16.98 26.81  
Intermediate  80.47 82.63 83.90 84.34 81.57   74.51 77.96 78.66 76.62 68.69  
Poor   9.41 7.49 6.92 5.40 2.59   16.87 11.49 8.85 6.39 4.50  
Salt intake, %      <0.001       <0.001 
ideal  5.65 5.65 5.61 7.35 12.85   5.98 7.57 9.38 10.44 15.60  
Intermediate  77.65 82.74 84.49 86.65 83.63   72.06 80.57 82.75 83.47 79.61  
Poor   16.71 11.62 9.91 5.99 3.52   21.96 11.86 7.87 6.09 4.79  
Total cholesterol, %      <0.001       <0.001 
Ideal   21.41 39.20 52.80 64.32 77.94   39.52 59.76 69.82 76.54 84.11  






Intermediate   41.18 38.44 34.74 27.87 18.84   38.52 30.74 25.31 19.86 14.57  
Poor   37.41 22.37 12.45 7.81 3.23   21.96 9.51 4.86 3.60 1.31  
Blood pressure, %      <0.001       <0.001 
Ideal   5.65 11.83 21.49 33.09 55.32   10.86 17.66 20.83 25.43 35.08  
Intermediate   46.82 54.94 59.14 57.10 40.76   54.65 57.50 58.77 60.15 57.97  
Poor   47.53 33.22 19.37 9.80 3.92   34.49 24.83 20.40 14.41 6.95  
Fasting blood glucose, %      <0.001       <0.001 
Ideal   80.47 82.84 86.02 87.38 89.45   75.37 78.62 79.84 81.15 84.61  
Intermediate   19.53 17.16 13.98 12.62 10.55   24.64 21.38 20.16 18.85 15.39  
Poor  -- -- -- -- --   -- -- -- -- --  
Abbreviation: CVH, ideal cardiovascular health;Q1=quintile1, Q2=quintile2, Q3=quintile3, Q4=quintile4, Q5=quintile5. 
 
  






Table S2. Odds ratios and 95% confidence intervals of diabetes according to the time weighted cumulative exposure of CVH. 
 
Group of cumulative exposure of CVH   
 
 Q1  Q2  Q3  Q4  Q5 One score increase P for trend 
Total, n 6864 6865 6865 6865 6864   
Case number, n (%) 426(6.21) 311(4.53) 255(3.71) 186(2.71) 123(1.79)   
Model 1 * 1.00 0.68(0.59-0.80) 0.55(0.47-0.65) 0.39(0.32-0.47) 0.26(0.22-0.33) 0.73(0.70-0.76) <0.001 
Model 2 † 1.00 0.67(0.58-0.78) 0.54(0.46-0.63) 0.38(0.31-0.45) 0.26(0.21-0.32) 0.72(0.69-0.76) <0.001 
Model 3 ‡ 1.00 0.72(0.62-0.85) 0.60(0.51-0.71) 0.42(0.35-0.52) 0.29(0.23-0.37) 0.76(0.72-0.79) <0.001 
Sex        
  Women,  39(7.75) 54(5.91) 63(4.95) 58(2.88) 61(1.67)   
  Model 3 ‡ 1.00 0.94(0.59-1.50) 0.92(0.58-1.45) 0.58(0.36-0.93) 0.37(0.22-0.62) 0.75(0.67-0.84) <0.001 
  Men 387(6.08) 257(4.32) 192(3.43) 128(2.64) 62(1.94)   
  Model 3 ‡ 1.00 0.70(0.59-0.83) 0.56(0.46-0.68) 0.41(0.33-0.51) 0.31(0.23-0.41) 0.76(0.72-0.80) <0.001 
P-interaction  0.321 0.105 0.413 0.933   
Age ,years        
<40ys  63(4.13) 39(2.67) 21(1.38) 15(0.91) 15(0.61)   
  Model 3 ‡ 1.00 0.74(0.49-1.13) 0.39(0.23-0.66) 0.26(0.14-0.48) 0.18(0.09-0.35) 0.70(0.62-0.80) <0.001 
40-59ys  304(6.55) 216(4.88) 181(4.15) 126(3.03) 80(2.25)   
  Model 3 ‡ 1.00 0.75(0.62-0.91) 0.65(0.53-0.80) 0.47(0.37-0.60) 0.32(0.24-0.43) 0.78(0.74-0.83) <0.001 
P-interaction  0.648 0.023 0.017 0.015   
≥60ys  59(8.44) 56(5.73) 53(5.42) 45(4.25) 28(3.24)   
  Model 3 ‡ 1.00 0.67(0.45-1.01) 0.66(0.44-1.00) 0.46(0.29-0.72) 0.42(0.25-0.70) 0.76(0.68-0.86) <0.001 
P-interaction  0.988 0.046 0.048 0.006   
Abbreviation: CVH, ideal cardiovascular health;time weighted cumulative exposure of CVH: (CVH1×time1-2 + CVH2×time2-3 + CVH3×time3-4)/( time1-2 + time2-3+ 
time3-4). Q1=quintile1, Q2=quintile2, Q3=quintile3, Q4=quintile4, Q5=quintile5. 






* Adjusted for age (years), sex. 
†Adjusted for as model 1 plus education level (elementary school, high school or college or above), income level (income≥800 ¥/month, ¥600-800, and income<600 
¥/month) and drinking (never, past, current, <1times/d or current, 1+times/d). 
‡ Adjusted for as model 2 plus High sensitive C-reactive protein, uric acid, resting heart rate at exam1, and medication usage before exam4.  
 
  






Table S3.Odds ratios and 95% confidence intervals of diabetes (exam2) in relation to quintile increase of baseline exposure of CVH (exam1). 
 
Group of baseline exposure of CVH   
 
Q1 Q2 Q3 Q4 Q5 One score increase P for trend 
Total, n 10422 10218 13701 14016 16817   
Case number, n (%) 794(7.61) 623(6.10) 677(4.94) 583(4.16) 437(2.60)   
Model 1 * 1.00 0.77(0.69-0.86) 0.61(0.55-0.68) 0.52(0.46-0.58) 0.35(0.31-0.39) 0.82(0.80-0.83) <0.001 
Model 2 † 1.00 0.75(0.67-0.83) 0.58(0.52-0.64) 0.48(0.43-0.54) 0.32(0.28-0.36) 0.80(0.78-0.82) <0.001 
Model 3 ‡ 1.00 0.79(0.70-0.88) 0.62(0.55-0.69) 0.53(0.47-0.60) 0.36(0.32-0.41) 0.82(0.80-0.84) <0.001 
Sex        
  Women,  49(9.42) 99(8.82) 94(4.13) 124(3.75) 119(1.68)   
  Model 3 ‡ 1.00 1.11(0.75-1.64) 0.53(0.36-0.79) 0.61(0.42-0.89) 0.37(0.25-0.54) 0.79(0.74-0.84) <0.001 
  Men 745(7.52) 524(5.76) 583(5.10) 459(4.29) 318(3.27)   
  Model 3 ‡ 1.00 0.75(0.67-0.85) 0.64(0.56-0.72) 0.52(0.46-0.60) 0.40(0.34-0.46) 0.84(0.81-0.86) <0.001 
P-interaction  0.143 0.131 0.746 0.035   
Age ,years        
<40ys  65(4.01) 46(2.73) 67(2.98) 43(1.59) 40(0.84)   
  Model 3 ‡ 1.00 0.73(0.49-1.08) 0.87(0.60-1.25) 0.49(0.32-0.75) 0.35(0.22-0.55) 0.84(0.77-0.90) <0.001 
40-59ys  593(8.11) 417(6.26) 416(4.79) 363(4.31) 272(2.94)   
Model 3 ‡ 1.00 0.77(0.67-0.88) 0.57(0.50-0.66) 0.52(0.45-0.60) 0.38(0.32-0.45) 0.82(0.80-0.85) <0.001 
P-interaction  0.552 0.167 0.188 0.024   
≥60ys  136(9.07) 160(8.55) 194(6.99) 177(6.16) 125(4.46)   
Model 3 ‡ 1.00 0.94(0.74-1.22) 0.75(0.59-0.96) 0.67(0.52-0.86) 0.47(0.36-0.62) 0.86(0.82-0.90) <0.001 
P-interaction  0.148 0.947 0. 018 0.002   
Abbreviation: CVH, ideal cardiovascular health; Q1=quintile1, Q2=quintile2, Q3=quintile3, Q4=quintile4, Q5=quintile5. 
* Adjusted for age (years), sex. 






†Adjusted for as model 1 plus education level (elementary school, high school or college or above), income level (income≥800 ¥/month, ¥600-800, and income<600 
¥/month) and drinking (never, past, current, <1times/d or current, 1+times/d). 
‡ Adjusted for as model 2 plus High sensitive C-reactive protein, uric acid, resting heart rate, and medication usageat exam1.






TableS4. Comparison of Demographic and Other Characteristics of Participants and Non-
Participants  
 Participants Non-Participants P-Value 
n 34323 52764  
Age (Years) 47.43 ± 11. 62 53.85 ± 12.97 <0.001 
Male Sex, n (%) 25961 (75.64) 43174(81.82) <0.001 
High School Educational Level or above, n (%) 8147 (23.75) 9289 (18.80) <0.001 
Income ≥¥800/month, n (%) 5140 (14.98) 6896(13.97) <0.001 
Current Smoker, n (%) 10438(30.41) 15647 (31.28) <0.001 
Current Alcohol Drinker, n (%) 5932 (17.29) 9108 (18.19) <0.001 
Physical Activity ≥80 min, n (%) 4609 (13.43) 8092 (16.44) <0.001 
High Salt Intake, n (%) 3566 (10.39) 5352 (10.86) 0.058 
Body Mass Index  (kg/m2) 24.89 ±3.42 24.81 ± 3.47 <0.001 
Systolic Blood Pressure (mmHg) 127.02 ± 19.30 131.66 ± 21.40 <0.001 
Diastolic Blood Pressure  (mmHg) 82.20 ± 11.26 83.54 ± 11.89 <0.001 
Fasting Blood Glucose Concentration (mmol/l) 5.02 ± 0.65 5.06 ± 0.69 <0.001 
Total Cholesterol Concentration (mmol/l) 4.87 ± 1.13 4.93 ± 1.11 <0.001 
High-Sensitive C-Reactive Protein 
Concentration (mg/L) 
0.68 (0.25-1.80) 0.85 (0.30-2.30) <0.001 
Uric Acid Concentration (μmol/L) 283.83 ± 81.52 294.79 ± 84.41 <0.001 
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